What is Myotronics?
Myotronics empowers dental professionals with state-of-the-art equipment and comprehensive educational courses focused on neuromuscular and sleep medicine. Their product suite, including the K7 Evaluation System and J5 Dental TENS unit, facilitates precise diagnosis and treatment for conditions such as Temporomandibular Joint Disorder (TMD) and sleep apnea. The company is dedicated to enhancing dental practices by integrating innovative techniques and technology, thereby improving patient care and practice revenue. Myotronics targets dentists seeking to broaden their patient base and adopt cutting-edge solutions.
How much funding has Myotronics raised?
Myotronics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Myotronics
PPP
Public-Private Partnership
What's next for Myotronics?
With its large-scale late-stage funding context, Myotronics is positioned for significant growth and market penetration. The recent strategic investment likely signals a phase of scaling operations, expanding product development, and potentially entering new markets or enhancing its educational outreach. The company's focus on specialized dental solutions suggests a strategic direction towards solidifying its leadership in neuromuscular and sleep medicine within the dental industry, leveraging its technological advancements to meet evolving patient and practitioner needs.
See full Myotronics company page
